Past, present and future of psychoneuroimmunology.

Toxicology

Institute of Pharmacology, Academy of Sciences of the Czech Republic, Prague.

Published: January 2000

Psychoneuroimmunology was for the first time comprehensively described about 20 years ago. The influence of mental status on the course and outcome of a number of diseases, however, was suspected a long time before. Also the links between mental affective disorders and the immune status were repeatedly suggested. The authors in this paper shortly reviewed the most important clinical as well as experimental evidence which at present strongly supports the concept of a close and bidirectional communication between central nervous, neuroendocrine and immune systems. The most important anatomical, physiological as well as pharmacological experimental data, which were obtained by the authors during 20 years of research in this field, are presented. The data strongly suggest that in the very next future we will not only better understand a very complex communication between mind and body, but also completely new types of compounds might become available.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0300-483x(99)00143-2DOI Listing

Publication Analysis

Top Keywords

future psychoneuroimmunology
4
psychoneuroimmunology psychoneuroimmunology
4
psychoneuroimmunology time
4
time comprehensively
4
comprehensively described
4
described years
4
years ago
4
ago influence
4
influence mental
4
mental status
4

Similar Publications

A reliability generalization meta-analysis of the internal consistency and test-retest reliability of the pre-sleep arousal scale (PSAS).

Sleep Med

December 2024

Government Hospitals, Manama, Bahrain; Department of Psychiatry, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain. Electronic address:

Purpose: The Pre-Sleep Arousal Scale (PSAS) is a self-report tool for assessing cognitive and somatic arousal before sleep. While the English version is well-validated, research on translations is limited. This meta-analysis examines PSAS translations' internal consistency and reliability.

View Article and Find Full Text PDF

Skin-brain dialogue in auto-inflammatory diseases: A new route to biomarkers?

Brain Behav Immun Health

December 2024

Pôle Hospitalo-Universitaire Psychiatrie Paris 15, GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Paris, France.

Autoinflammatory diseases (AID) are rare systemic inflammatory disorders due to monogenic or polygenic dysfunction of innate immunity. They affect many organs including the brain and the skin. The spectrum of these diseases has been rapidly expanding recently due to newly developed diagnostic tools.

View Article and Find Full Text PDF

Cisgender women living with HIV experience elevated cardiovascular disease (CVD) risk that increases with age, a concern given extended life expectancies for people living with HIV. The CVD risk disparity among cisgender women aging with HIV is understudied and remains unclear. Taking a psychoneuroimmunology approach, given this group's intersecting marginalized identities, one potential driver of the disparity is intersectional stigma.

View Article and Find Full Text PDF

An Extension to the stress-buffering model: Timing of support across the lifecourse.

Brain Behav Immun Health

December 2024

Department of Psychology, Carnegie Mellon University, 4825 Frew St, Suite 354E, Pittsburgh, PA, 15213, USA.

Children and adolescents exposed to severe stressors exhibit poorer health across the lifespan. However, decades of research evaluating the Stress-Buffering model suggests that social support can attenuate stressors' negative impacts. Psychoneuroimmunology research in this area has shifted from asking whether support buffers stress to when and why support would succeed (or fail) to confer protection.

View Article and Find Full Text PDF

What can the psychoneuroimmunology of yoga teach us about depression's psychopathology?

Brain Behav Immun Health

December 2024

King's College London, Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, London, United Kingdom.

Article Synopsis
  • Over 30% of depression patients remain untreated, often linked to sub-clinical inflammation and complex pathways beyond standard anti-inflammatory treatments.
  • Mind-body therapies, especially yoga, show promise in reversing negative cognitive functions and neurobiological pathways associated with depression, and may work better when combined with other therapies.
  • Future treatment approaches should integrate diverse methods—pharmacological, behavioral, and mind-body therapies—into a multi-disciplinary health team to better address treatment-resistant depression.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!